Works by Bendell, Johanna

Results: 100
    1
    2
    3
    4
    5
    6

    Targeted Therapy in Rectal Cancer.

    Published in:
    Oncology (08909091), 2007, v. 21, n. 9, p. 1055
    By:
    • Willett, Christopher G.;
    • Duda, Dan G.;
    • Czito, Brian G.;
    • Bendell, Johanna C.;
    • Clark, Jeffrey W.;
    • Jain, Rakesh K.
    Publication type:
    Article
    7
    8
    9

    Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum].

    Published in:
    International Journal of Nanomedicine, 2019, v. 14, p. 5751, doi. 10.2147/IJN.S207276
    By:
    • Wu, Huali;
    • Infante, Jeffrey R;
    • Keedy, Vicki L;
    • Jones, Suzanne F;
    • Chan, Emily;
    • Bendell, Johanna C;
    • Lee, Wooin;
    • Kirschbrown, Whitney P;
    • Zamboni, Beth A;
    • Ikeda, Satoshi;
    • Kodaira, Hiroshi;
    • Rothenberg, Mace L;
    • III, Howard A Burris;
    • Zamboni, William C
    Publication type:
    Article
    10

    Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors.

    Published in:
    International Journal of Nanomedicine, 2015, v. 10, p. 1201, doi. 10.2147/IJN.S62911
    By:
    • Huali Wu;
    • Infante, Jeffrey R.;
    • Keedy, Vicki L.;
    • Jones, Suzanne F.;
    • chan, Emily;
    • Bendell, Johanna C.;
    • lee, Wooin;
    • Kirschbrown, Whitney P.;
    • Zamboni, Beth A.;
    • Ikeda, Satoshi;
    • Kodaira, Hiroshi;
    • Rothenberg, Mace L.;
    • Burris III, Howard A.;
    • Zamboni, William C.
    Publication type:
    Article
    11
    12
    13

    First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2443, doi. 10.1007/s00262-023-03430-6
    By:
    • Bendell, Johanna;
    • LoRusso, Patricia;
    • Overman, Michael;
    • Noonan, Anne M.;
    • Kim, Dong-Wan;
    • Strickler, John H.;
    • Kim, Sang-We;
    • Clarke, Stephen;
    • George, Thomas J.;
    • Grimison, Peter S.;
    • Barve, Minal;
    • Amin, Manik;
    • Desai, Jayesh;
    • Wise-Draper, Trisha;
    • Eck, Steven;
    • Jiang, Yu;
    • Khan, Anis A.;
    • Wu, Yuling;
    • Martin, Philip;
    • Cooper, Zachary A.
    Publication type:
    Article
    14
    15

    A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.

    Published in:
    2015
    By:
    • Bendell, Johanna C.;
    • Kelley, Robin K.;
    • Shih, Kent C.;
    • Grabowsky, Jennifer A.;
    • Bergsland, Emily;
    • Jones, Suzanne;
    • Martin, Thomas;
    • Infante, Jeffrey R.;
    • Mischel, Paul S.;
    • Matsutani, Tomoo;
    • Xu, Shuichan;
    • Wong, Lilly;
    • Liu, Yong;
    • Wu, Xiaoling;
    • Mortensen, Deborah S.;
    • Chopra, Rajesh;
    • Hege, Kristen;
    • Munster, Pamela N.
    Publication type:
    journal article
    16
    17

    A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.

    Published in:
    Oncology, 2018, v. 94, n. 6, p. 329, doi. 10.1159/000485384
    By:
    • Thomas, Melanie B.;
    • Garrett-Mayer, Elizabeth;
    • Anis, Munazza;
    • Anderton, Kate;
    • Bentz, Tricia;
    • Edwards, Andie;
    • Brisendine, Alan;
    • Weiss, Geoffrey;
    • Siegel, Abby B.;
    • Bendell, Johanna;
    • Baron, Ari;
    • Duddalwar, Vinay;
    • El-Khoueiry, Anthony
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 95, doi. 10.1007/s00280-012-1889-8
    By:
    • Vlahovic, Gordana;
    • Meadows, Kellen;
    • Uronis, Hope;
    • Morse, Michael;
    • Blobe, Gerard;
    • Riedel, Richard;
    • Zafar, S.;
    • Alvarez-Secord, Angeles;
    • Gockerman, Jon;
    • Starodub, Alexander;
    • Ready, Neal;
    • Anderson, Elizabeth;
    • Bendell, Johanna;
    • Hurwitz, Herbert
    Publication type:
    Article
    28
    29
    30
    31

    A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 1, p. 177, doi. 10.1002/ijc.30049
    By:
    • Eng, Cathy;
    • Bessudo, Alberto;
    • Hart, Lowell L.;
    • Severtsev, Aleksey;
    • Gladkov, Oleg;
    • Müller, Lothar;
    • Kopp, Mikhail V.;
    • Vladimirov, Vladimir;
    • Langdon, Robert;
    • Kotiv, Bogdan;
    • Barni, Sandro;
    • Hsu, Ching;
    • Bolotin, Ellen;
    • von Roemeling, Reinhard;
    • Schwartz, Brian;
    • Bendell, Johanna C.
    Publication type:
    Article
    32
    33

    Regorafenib Prior to Selective Internal Radiation Therapy Using <sup>90</sup>Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.

    Published in:
    Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00624
    By:
    • Kennedy, Andrew;
    • Shipley, Dianna;
    • Shpak, Max;
    • Blakely, Laura;
    • Hemphill, Brian;
    • Shih, Kent;
    • Lane, Cassie;
    • Zimmerman, Lisa;
    • McKenzie, Andrew;
    • Mainwaring, Mark;
    • Peyton, James D.;
    • Zubkus, John;
    • Wright, David;
    • Singh, Jaswinder;
    • Bendell, Johanna C.
    Publication type:
    Article
    34
    35

    Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
    By:
    • Chau, Ian;
    • Penel, Nicolas;
    • Soriano, Andres O.;
    • Arkenau, Hendrik-Tobias;
    • Cultrera, Jennifer;
    • Santana-Davila, Rafael;
    • Calvo, Emiliano;
    • Le Tourneau, Christophe;
    • Zender, Lars;
    • Bendell, Johanna C.;
    • Mi, Gu;
    • Gao, Ling;
    • McNeely, Samuel Clark;
    • Oliveira, Joana M.;
    • Ferry, David;
    • Herbst, Roy S.;
    • Fuchs, Charles S.
    Publication type:
    Article
    36

    Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 5, p. 966, doi. 10.1002/cncr.34016
    By:
    • Emamekhoo, Hamid;
    • Olsen, Mark R.;
    • Carthon, Bradley C.;
    • Drakaki, Alexandra;
    • Percent, Ivor J.;
    • Molina, Ana M.;
    • Cho, Daniel C.;
    • Bendell, Johanna C.;
    • Gordan, Lucio N.;
    • Rezazadeh Kalebasty, Arash;
    • George, Daniel J.;
    • Hutson, Thomas E.;
    • Arrowsmith, Edward R.;
    • Zhang, Joshua;
    • Zoco, Jesus;
    • Johansen, Jennifer L.;
    • Leung, David K.;
    • Tykodi, Scott S.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
    By:
    • Pietrantonio, Filippo;
    • Fucà, Giovanni;
    • Rossini, Daniele;
    • Schmoll, Hans‐Joachim;
    • Bendell, Johanna C.;
    • Morano, Federica;
    • Antoniotti, Carlotta;
    • Corallo, Salvatore;
    • Borelli, Beatrice;
    • Raimondi, Alessandra;
    • Marmorino, Federica;
    • Niger, Monica;
    • Boccaccino, Alessandra;
    • Masi, Gianluca;
    • Lonardi, Sara;
    • Boni, Luca;
    • Braud, Filippo;
    • Di Bartolomeo, Maria;
    • Falcone, Alfredo;
    • Cremolini, Chiara
    Publication type:
    Article
    45

    Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474
    By:
    • Bendell, Johanna;
    • Sharma, Sunil;
    • Patel, Manish R.;
    • Windsor, Kevin S.;
    • Wainberg, Zev A.;
    • Gordon, Michael;
    • Chaves, Jorge;
    • Berlin, Jordan;
    • Brachmann, Carrie Baker;
    • Zavodovskaya, Marianna;
    • Liu, JieJane;
    • Thai, Dung;
    • Bhargava, Pankaj;
    • Shah, Manish A.;
    • Khan, Saad A.;
    • Starodub, Alexander
    Publication type:
    Article
    46

    The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e451, doi. 10.1634/theoncologist.2019-0291
    By:
    • Bendell, Johanna C.;
    • Sauri, Tamara;
    • Gracián, Antonio Cubillo;
    • Alvarez, Rafael;
    • López‐López, Carlos;
    • García‐Alfonso, Pilar;
    • Hussein, Maen;
    • Miron, Maria‐Luisa Limon;
    • Cervantes, Andrés;
    • Montagut, Clara;
    • Vivas, Cristina Santos;
    • Bessudo, Alberto;
    • Plezia, Patricia;
    • Moons, Veerle;
    • Andel, Johannes;
    • Bennouna, Jaafar;
    • Westhuizen, Andre;
    • Samuel, Leslie;
    • Rossomanno, Simona;
    • Boetsch, Christophe
    Publication type:
    Article
    47
    48
    49

    A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.

    Published in:
    Oncologist, 2017, v. 22, n. 12, p. 1427, doi. 10.1634/theoncologist.2017-0066
    By:
    • Ko, Andrew H.;
    • Murphy, Patrick B.;
    • Peyton, James D.;
    • Shipley, Dianna L.;
    • Al‐Hazzouri, Ahmed;
    • Rodriguez, Francisco A.;
    • Womack, Mark S.;
    • Xiong, Henry Q.;
    • Waterhouse, David M.;
    • Tempero, Margaret A.;
    • Guo, Shuangli;
    • Lane, Cassie M.;
    • Earwood, Chris;
    • DeBusk, Laura M.;
    • Bendell, Johanna C.
    Publication type:
    Article
    50